Tissue Analysis Services, Pharma Regulatory Support, Clinical Diagnostics, Diagnostic Biomarker, Drug Development, Scientists, Immuno-Oncology Drug Development, Biomarker Strategy, Companion Diagnostics, CDx, Image Analysis Technology, Global Regulatory Strategy, Accelerate Trials, Companion Diagnostic Biomarker - Flagship Biosciences

New manuscript published in Scientific Reports
A Digital Assay to Streamline PD-L1 IHC
Read more about our research

Content Library

Prepare your team for success with the insights and strategies for accelerated and cost-effective drug development.

Review the content below to learn how spatial biology services can empower your drug development, research, and clinical trials.

Our Process at Flagship Biosciences

Get better data with more actionable insights
Learn the details of our unique tissue analysis process

Driving Your Biomarker Strategy: Facts by the Numbers

View our resume and history to learn why Flagship is the premier partner for your study
See the full list of spatial biology services that empower confident clinical decision making
See the benefits with a fully integrated team of scientists and pathologists

Digital Pathology Implementation Benefits

Improve ROI, accelerate trials, and minimize budget impacts
Minimize recruitment costs and other clinical trial expenses
Discover cost benefits of Flagship’s image analysis platform

eGuidebook: Accelerating Drug Development Through Innovative Tissue Analysis

Strategies to accelerate immune-oncology drug development
Discover accelerating technologies
Steps to streamline your drug development program

Phase 1 Through Companion Diagnostics (CDx) Support

Understand how biomarker selection impacts the probability of success
Learn how Flagship can help at each stage of development before launch
Consider the benefits of contextual biomarker data services

Global Regulatory Strategy and Regulatory Submission Support

Get regulatory support to aid each phase of your drug development process
Flagship provides both advice and preparation for regulatory submissions
Learn how our image analysis platform can strengthen your submission

READY TO TAKE THE NEXT STEP?

Our Services

Pharma

Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.

Clinical Diagnostics

Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.

Flagship carefully tracks our tissue to ensure we can analyze every assay and stay on schedule.

We are trying to bridge from the discovery stage to clinical development. Flagship's pathologists and scientists provide critical input and the company helps us organize and analyze an incredible amount of data. I highly recommend Flagship for its expertise and support for drug development projects.

During clinical trials, I interact with our manufacturing, legal, pre-clinical, and biomarker teams. Our Flagship project manager understands our tight timeline and ensures delivery of the data we need, when we need it.

We are pleased to partner with Flagship Biosciences to integrate their machine learning/AI tools to provide cancer marker detection.

Flagship’s image analysis experts are flexible and willing to work with us to develop projects that meet the changing needs of our clinical trials drug development.

Flagship has a high reputation as a supplier of advanced IHC services and their CAP-CLIA environment is a perfect complement to our own testing facilities.

The ease of leveraging Flagship’s powerful solution is yet another massive differentiator of the company. Clients need not have to change their existing workflows, investments in technology, or even the assays that they use.